Hello, Fool! | Login | Signup | My Fool
Jan 9, 2009 9:33 PM ET | Feedback | Site Changes | Help
A specialty pharmaceutical company which is engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used primarily to treat and manage pain.
View Ticker Page (ENDP)
Results 21 - 29 of 29 : 123
Recs
ranaxy (42.94) Submitted: 6/01/07 1:16 PM : Start Price: $27.96 ENDP Score: 13.24
I am not sure why I added this into my portfolio, but its doing great! I found it when researching RDY, and S&P reports on RDY included ENDP as a competitor. Hopefully, someday I shall update this as to why I think this stock is moving up.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
mnsw (24.44) Submitted: 1/19/07 11:43 AM : Start Price: $29.89 ENDP Score: 9.45
Lidoderm is still a cash cow, although generic risks will be coming soon. The pipeline has numerous drugs in phase 2 and 3 that
Wicon (91.81) Submitted: 1/19/07 4:49 PM : Start Price: $29.78 ENDP Score: 9.83
This company is specialized in a niche area - pain management, and is clearly the market leader.Expiration of Lidoderm patents is still years away, and the company has already launched new products and has two more new products in phase III. It ha...
OzSmall (87.88) Submitted: 1/20/07 8:37 AM : Start Price: $29.78 ENDP Score: 9.83
pressure on lidoderm patents will have to keep them looking for acquisitions to protect market share and $$
prumoose (< 20) Submitted: 1/21/07 4:36 PM : Start Price: $29.78 ENDP Score: 9.83
hysteria/overreaction over the
shatch24 (26.13) Submitted: 4/30/07 10:32 PM : Start Price: $30.76 ENDP Score: 9.78
Solid group of pain medications on the market, with several more in the pipeline. Even at a 10% earnings growth (10/5/3) over the next five years, the DCF puts this stock in the mid 40s. Up that growth to 15% and its in the 50s.
Thegreatdoodle (< 20) Submitted: 9/06/07 8:15 PM : Start Price: $31.89 ENDP Score: 6.50
I like the PE and the low public profile of this company
not2eager (95.34) Submitted: 9/20/07 2:08 PM : Start Price: $31.07 ENDP Score: 10.82
Look at the weekly chart. In an upward channel. Makes money in an undervalued sector. Cheap P/E, an in the low end of the channel.
CharlieBombay (28.58) Submitted: 1/09/09 9:03 AM : Start Price: $21.70 ENDP Score: 1.21
IBB Health. Low Debt. Recent selloff.
Terms & Conditions
RSS Headlines
Fool UK